[Hyperglucagonemia in patients with chronic renal failure treated by repeated hemodialysis]. 1980

S Czekalski, and W Słuczanowski, and M Gryczyńska, and M Toczkowski, and I Gołebiowska, and U Nowotko

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S Czekalski, and W Słuczanowski, and M Gryczyńska, and M Toczkowski, and I Gołebiowska, and U Nowotko
October 1988, Wiadomosci lekarskie (Warsaw, Poland : 1960),
S Czekalski, and W Słuczanowski, and M Gryczyńska, and M Toczkowski, and I Gołebiowska, and U Nowotko
April 1972, Annales de chirurgie thoracique et cardio-vasculaire,
S Czekalski, and W Słuczanowski, and M Gryczyńska, and M Toczkowski, and I Gołebiowska, and U Nowotko
January 1974, Journal de radiologie, d'electrologie, et de medecine nucleaire,
S Czekalski, and W Słuczanowski, and M Gryczyńska, and M Toczkowski, and I Gołebiowska, and U Nowotko
January 1989, Wiadomosci lekarskie (Warsaw, Poland : 1960),
S Czekalski, and W Słuczanowski, and M Gryczyńska, and M Toczkowski, and I Gołebiowska, and U Nowotko
October 1985, Journal of neurochemistry,
S Czekalski, and W Słuczanowski, and M Gryczyńska, and M Toczkowski, and I Gołebiowska, and U Nowotko
November 2005, Polskie Archiwum Medycyny Wewnetrznej,
S Czekalski, and W Słuczanowski, and M Gryczyńska, and M Toczkowski, and I Gołebiowska, and U Nowotko
January 1992, Klinicheskaia meditsina,
S Czekalski, and W Słuczanowski, and M Gryczyńska, and M Toczkowski, and I Gołebiowska, and U Nowotko
February 1969, Metabolism: clinical and experimental,
S Czekalski, and W Słuczanowski, and M Gryczyńska, and M Toczkowski, and I Gołebiowska, and U Nowotko
May 1987, Clinical chemistry,
S Czekalski, and W Słuczanowski, and M Gryczyńska, and M Toczkowski, and I Gołebiowska, and U Nowotko
September 2005, Polskie Archiwum Medycyny Wewnetrznej,
Copied contents to your clipboard!